Molecular diagnostics companies develop and supply technologies that detect disease-associated DNA, RNA and other defined molecular signatures in human clinical samples. Their products support infectious disease testing, genetic diagnosis, cancer profiling and precision medicine, from central laboratory workflows to rapid near-patient assays.
This category includes companies working on:
Browse 51 UK molecular diagnostics companies below.
Decentralised molecular and multiomic diagnostics as a service
Molomix Bioscience is a Welsh biotechnology company providing decentralised molecular and multiomic diagnostics for research, clinical and applied testing settings. The company offers subscription-based access to sequencing and molecular diagnostic platforms, supported by consumables, training and technical support.…
Genomic diagnostics products for cytogenetics, oncology and rare disease
Oxford Gene Technology is a genomic diagnostics company developing and manufacturing hybridisation-based reagents and assays for clinical and research laboratories. Its product portfolio spans FISH probes, chromosomal microarrays and next-generation sequencing panels, enabling detection of chromosomal abnormalities…
Real-time PCR instruments and automated liquid handling systems
Bio Molecular Systems is an Australian laboratory instrument manufacturer with a dedicated UK sales operation. Its portfolio includes compact real-time PCR cyclers, automated pipetting and liquid handling platforms, and associated workflow software. Applications span gene expression analysis, molecular diagnostics,…
GCP-accredited oncology molecular diagnostics for clinical trials and research
The Cancer Molecular Diagnostics Laboratory is an ISO 15189-accredited molecular diagnostics facility within the University of Cambridge Department of Oncology, jointly funded by CRUK and NIHR. Operating to GCP and GCLP standards, it provides next-generation sequencing, circulating tumour DNA analysis, liquid biopsy…
AI-powered portable diagnostics platform for field-based disease testing
Vidiia is a diagnostics company developing AI-powered, portable molecular testing devices for point-of-care and field-based disease detection. Its platform combines RT-LAMP assay chemistry with smartphone-connected artificial intelligence to interpret results, and has received UK regulatory approval for medical use.…
In vitro diagnostic reagents, test kits and analysers for clinical laboratories
Fortress Diagnostics is a Northern Ireland-based manufacturer of in vitro diagnostic products, supplying clinical chemistry reagents, immunoassays, haematology reagents, haemostasis consumables, serology test kits, quality controls and calibrators, and diagnostic instrumentation to hospitals, blood banks, and research…
Automated molecular diagnostics for HLA typing and blood group testing
MC Diagnostics is a specialist molecular diagnostics company developing and manufacturing automated multiplexed assay solutions for clinical and reference laboratories. The company's proprietary platform delivers proven diagnostic assays for HLA typing and blood group testing, supported by integrated image capture and…
Non-invasive oral cancer screening using genomics and cell-free DNA
Wisdom Bioscience is a biotechnology company developing a non-invasive oral cancer screening platform that integrates next-generation sequencing and cell-free DNA analysis with saliva-based sample collection. The platform is designed to enable early detection of oral cancer through routine dental appointments,…
Reproductive genetic testing and embryo screening for fertility clinics
Igenomix UK is a reproductive genetics laboratory providing diagnostic testing services for fertility clinics and reproductive medicine specialists. Its services include preimplantation genetic testing for chromosomal abnormalities and inherited conditions, alongside carrier screening and endometrial assessments. The…
Diagnostic reagents, instruments and quality controls for clinical and research laboratories
Randox Laboratories is a global manufacturer of in vitro diagnostic reagents, clinical chemistry analysers, quality control materials, and biochip array technology for laboratory medicine. Products serve clinical, research, molecular, forensic toxicology, food safety, and veterinary laboratory markets across more than…
Blood-based microRNA test for multi-cancer early detection
Xgenera is a diagnostics company developing a blood test for the early detection of multiple cancers from a single sample. The test measures circulating microRNA biomarkers using PCR-based methods and applies machine learning to identify signals from up to 12 common cancers before symptoms appear. The company is…
Solutions for genomics, diagnostics and precision medicine
QIAGEN is a global provider of sample preparation, molecular diagnostics, and genomics solutions for pharmaceutical, clinical, and research applications. Its UK headquarters at Citylabs 2.0, Manchester serves as the company's global centre of excellence for precision medicine and companion diagnostics, co-developing…
Liquid biopsy NGS kits and genomic diagnostic services
Nonacus is a developer of next-generation sequencing reagents and library preparation kits for liquid biopsy and tissue-based genomic analysis. Its target enrichment and cell-free DNA workflow products support cancer detection, treatment stratification, and longitudinal monitoring. Through its clinical services…
qPCR assays and reagents for infectious disease and pathogen detection
Primerdesign is a Manchester-based molecular diagnostics company designing, manufacturing, and supplying real-time qPCR assays and reagents for pathogen detection across human health, animal health, food safety, and environmental monitoring. Its catalogue of over 400 CE-IVD and research-use-only detection kits covers…
RNA sequencing liquid biopsy for cardiovascular and complex disease screening
MultiplAI Health is a Cambridge biotech developing a whole-blood RNA sequencing test for early screening of cardiovascular and other complex diseases. Its platform combines transcriptomic profiling of blood samples with a patented data transformation process and proprietary deep learning algorithms to generate…
Portable multiplex PCR molecular diagnostic platform for point-of-care use
QuantuMDx is a medical technology company developing a battery-operated, handheld molecular diagnostic system that delivers multiplex PCR results from a single-use reagent cassette within 35 minutes. Designed for point-of-care and resource-limited settings, the CE-IVD marked device supports assays for respiratory…
Molecular and digital biomarkers for personalised cancer treatment
Oxford Cancer Biomarkers is a precision oncology diagnostics company developing molecular and digital pathology tests to support personalised cancer treatment. Its pharmacogenomic assays assess inherited variants associated with fluoropyrimidine chemotherapy toxicity, while its algorithm-driven pathology tools analyse…
PCR-based diagnostic kits, instruments and consumables manufacturer
Advanced Molecular Diagnostics is a manufacturer of molecular diagnostic instruments, kits, and consumables for clinical and food safety applications. Its CE-IVD certified product portfolio includes real-time qPCR assay kits for infectious diseases, genetic mutations, respiratory pathogens, sexually transmitted…
Molecular assay platform for genomic profiling in cancer diagnostics
Biofidelity is a Cambridge-based genomic technology company developing molecular assays for cancer biomarker detection in tissue and liquid biopsy samples. Its proprietary platform enables ultra-sensitive detection of somatic mutations at low variant allele fractions using a simplified four-step qPCR workflow, without…
DNA methylation blood tests for ovarian and pancreatic cancers
GenoME Diagnostics is a biotechnology company developing molecular blood tests for cancer detection and monitoring. Its liquid biopsy platform identifies DNA methylation and fragmentomic biomarkers, combining them into multiplexed droplet digital PCR assays. Its lead test targets ovarian cancer recurrence and…
This category covers companies developing, producing or providing human-health molecular diagnostic technologies, including clinically directed assays in development. It focuses on disease-related nucleic acid and defined molecular-target detection rather than general-purpose research-only PCR or sequencing products. Dedicated clinical molecular diagnostic manufacturers, laboratories and relevant OEM suppliers may qualify; an investigational assay must not be described as clinically authorised unless that status is evidenced.